SHANGHAI (Reuters) - A crackdown on corruption and pricing in China's fast-growing pharmaceutical market has squeezed profits and margins, raising a red flag to global Big Pharma that the days of easy growth in the country may be over. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/8-HNc0oBpYE/story01.htm
Read More
No comments:
Post a Comment